text.skipToContent text.skipToNavigation
Need help? Please contact us

Cell Line Nucleofector™ Kit L

Cell Line Nucleofector™ Kit L

Catalog #: VCA-1005

For efficient transfection of cell lines, e.g. 3T3-L1 ad, DU145, EL4, IMR-32 or MDCK, in the NucleofectorTM I/II/2b Device

Compare

Select Size

 683.00 CHF
ST

Product Overview

The Cell Line NucleofectorTM Kit L is one of our five NucleofectorTM Kits suited for transfecting cell lines in the NucleofectorTM 2b Device.

This kit has been determined to be optimal for transfecting following cell types:
3T3-L1 ad
A-10
BHK-21
BxPC-3
DU145
EL4
FDC-P1
GH3 H9c2 (2-1)
HeLa S3
IMR-32
KG-1a
L-428 (DSMZ)
MDCK
MDCK II (ECACC)
MOLT-4
MV-4-11
NTERA-2 cl.D1
WEHI-231

The respective cell type-specific Optimized Protocol or recommendation is available under "Instructions" or in our knowledge database. In this Optimized Protocol the best Nucleofection conditions are indicated. In addition, we share our experience and knowledge for treatment of this cell type.

 

Request More Info

Benefits

  • High transfection efficiencies in difficult-to-transfect cell lines

Applications

  • Transfection of cell numbers in the range of 2 × 105 to 2 × 107 cells 
  • Low-throughput transfection in single cuvette format

Storage and Content

  • 2.25 mL NucleofectorTM Solution L
    0.5 mL Supplement 1
    30 µg pmaxGFPTM Vector (0.5 μg/μl in 10 mM Tris pH 8.0)
    25 Aluminum cuvette (100 µL),
    25 Single use pipettes

Return to Top

SDS, CoA, and Instructions

Certificate of Analysis (CoA)

Please enter Lot Number, including all zeros, located on the product label and please take into account that it is case sensitive.

Return to Top

Subscribe to our eNewsletter

Keep up to speed on the latest scientific developments, events, tips and tools from Lonza.

Interested in our Webinars?

Need a break from your daily routine? Grab a coffee and check out our free webinars. 

Knowledge Center

Need technical data?

Browse our Cell and Transfection, Citation, FAQ and Culture Media Technical Databases.